| payload |
{"created_at":"2026-04-21T12:20:48.730 {"created_at":"2026-04-21T12:20:48.730501+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/quest-diagnostics-raises-2026-eps-revenue-guidance","value":{"fp":"9aaa27fb59466f72","kind":"unusual_volume","published_at":"2026-04-21T11:21:37+00:00","source":"Nasdaq Markets","summary":"(RTTNews) - Quest Diagnostics (DGX) said, for full year 2026, the company now expects adjusted diluted EPS in a range of $10.63 $10.83, revised from prior guidance range of $10.50 $10.70. Net revenues are now expected in a range of $11.78 billion to $11.90 billion, updated from p","tickers":["DGX"],"title":"Quest Diagnostics Raises 2026 EPS, Revenue Guidance","url":"https://www.nasdaq.com/articles/quest-diagnostics-raises-2026-eps-revenue-guidance"}}... |